Murai Nobuhito, Tsukamoto Mina, Tamura Seiji, Aoki Toshiaki, Matsuoka Nobuya
Pharmacology Research Laboratories, Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.
Pharmacology Research Laboratories, Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.
Eur J Pharmacol. 2014 Jun 15;733:54-61. doi: 10.1016/j.ejphar.2014.03.038. Epub 2014 Apr 1.
The (+)-isomer of indeloxazine AS1069562 exerts multiple pharmacological actions including the inhibition of serotonin (5-HT) and norepinephrine reuptake and analgesia in experimental animal pain models. Here, we evaluated the antinociceptive effects of AS1069562 and the antidepressants duloxetine and amitriptyline in mouse models of prostaglandin-induced spinal hypersensitivity. Prostaglandin E2 (PGE2) and F2α (PGF2α) were intrathecally administered to induce spinal hypersensitivity, causing tactile allodynia in mice. Allodynia induced by PGF2α but not by PGE2 was suppressed by desensitization of C-fibers with systemic pretreatment with resiniferatoxin. C-fiber hyperexcitability might therefore play a role in allodynia induced by PGF2α but not PGE2. In the PGE2-induced allodynia model, AS1069562 and duloxetine significantly suppressed allodynia, whereas amitriptyline did not. In the PGF2α-induced allodynia model, AS1069562 and amitriptyline significantly ameliorated allodynia, whereas duloxetine did not. To demonstrate the broad effects of AS1069562 compared to duloxetine, additional studies were conducted to elucidate other target mechanisms of AS1069562 beyond 5-HT and norepinephrine reuptake inhibition. AS1069562 exhibited affinity for both 5-HT1A and 5-HT3 receptors, and the analgesic effect of AS1069562 on PGF2α-induced allodynia was significantly blocked by the 5-HT1A receptor antagonist (S)-WAY100135 and the 5-HT3 receptor agonist SR57227. Taken together, these results indicate that AS1069562 inhibits both C-fiber- and non-C-fiber-dependent prostaglandin-induced allodynia, while duloxetine inhibits only non-C-fiber-triggered allodynia, and amitriptyline inhibits only C-fiber-triggered allodynia. These broad antinociceptive effects of AS1069562 may be due not only to 5-HT and norepinephrine reuptake inhibition but also to its effects on 5-HT receptors such as 5-HT1A and 5-HT3 receptors.
茚达品AS1069562的(+)-异构体具有多种药理作用,包括在实验动物疼痛模型中抑制5-羟色胺(5-HT)和去甲肾上腺素再摄取以及产生镇痛作用。在此,我们评估了AS1069562以及抗抑郁药度洛西汀和阿米替林在前列腺素诱导的脊髓超敏反应小鼠模型中的抗伤害感受作用。鞘内注射前列腺素E2(PGE2)和F2α(PGF2α)以诱导脊髓超敏反应,从而导致小鼠出现触觉异常性疼痛。用树脂毒素进行全身预处理使C纤维脱敏后,PGF2α而非PGE2所诱导的异常性疼痛受到抑制。因此,C纤维的过度兴奋可能在PGF2α而非PGE2所诱导的异常性疼痛中起作用。在PGE2诱导的异常性疼痛模型中,AS1069562和度洛西汀可显著抑制异常性疼痛,而阿米替林则不能。在PGF2α诱导的异常性疼痛模型中,AS1069562和阿米替林可显著改善异常性疼痛,而度洛西汀则不能。为了证明与度洛西汀相比AS1069562具有更广泛的作用,我们开展了额外的研究以阐明AS1069562除抑制5-HT和去甲肾上腺素再摄取之外的其他作用靶点机制。AS1069562对5-HT1A和5-HT3受体均具有亲和力,并且AS1069562对PGF2α诱导的异常性疼痛的镇痛作用被5-HT1A受体拮抗剂(S)-WAY100135和5-HT3受体激动剂SR57227显著阻断。综上所述,这些结果表明,AS1069562可抑制C纤维依赖性和非C纤维依赖性前列腺素诱导的异常性疼痛,而度洛西汀仅抑制非C纤维触发的异常性疼痛,阿米替林仅抑制C纤维触发的异常性疼痛。AS1069562的这些广泛的抗伤害感受作用可能不仅归因于其对5-HT和去甲肾上腺素再摄取的抑制,还归因于其对5-HT受体(如5-HT1A和5-HT3受体)的作用。